Skip to main
INDV
INDV logo

Indivior PLC (INDV) Stock Forecast & Price Target

Indivior PLC (INDV) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Indivior PLC has demonstrated robust growth in its product line, with units dispensed escalating by 19% from the previous quarter, and a notable increase of 37% in patients on Sublocade treatment year-over-year, signaling strong demand in the market. The company's strategic emphasis on expanding the Sublocade network saw a remarkable 60% increase in injections at alternate sites of care, further enhancing accessibility and patient outreach. With projected sales for Sublocade reaching $820M-$880M for 2024 and an attractive valuation at only ~3x EV/2025 EBITDA amidst a clear growth trajectory, the overall risk/reward profile for Indivior's stock appears compelling.

Bears say

Indivior PLC's revenue guidance for 2024 has been reduced to a range of $725 million to $745 million for Sublocade, indicating a downward revision due to competitive pressures from Braeburn's Brixadi and inventory challenges. Additionally, the company's expectations for annual sales growth have been diminished, reflecting a lower anticipated growth rate of 17% compared to 2023, down from previously expected growth rates. The altered outlook is compounded by headwinds related to Medicaid disenrollments, suggesting a concerning trend in both market dynamics and operational execution that may hinder future profitability.

Indivior PLC (INDV) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Indivior PLC and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Indivior PLC (INDV) Forecast

Analysts have given Indivior PLC (INDV) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Indivior PLC (INDV) has a Strong Buy consensus rating as of Jul 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Indivior PLC (INDV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.